Form 4: Ginkgo Bioworks Director Myrtle Potter Acquires Over 10,000 Shares Through RSU Vesting

Ginkgo Bioworks Holdings, Inc. Director Myrtle S. Potter acquired 10,822 shares of Class A Common Stock on June 11, 2025, through the vesting of previously granted Restricted Stock Units.

Summary

• Myrtle S. Potter, a Director of Ginkgo Bioworks Holdings, Inc. (DNA), reported a transaction on June 11, 2025.
• The transaction involved the acquisition of 10,822 shares of Class A Common Stock.
• These shares were acquired through the vesting of Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.
• The RSUs were granted on June 13, 2024, and vested in full on June 11, 2025, in accordance with the Issuer's Non-Employee Director Compensation Program.
• The vesting was contingent on Ms. Potter continuing her service as a Non-Employee Director through the vesting date, which was the day immediately prior to the company's next Annual Meeting of Shareholders after the grant date.
• Following this transaction, Ms. Potter beneficially owns 10,822 shares of Class A Common Stock directly.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While a routine compensation event, it signifies continued director alignment and direct ownership, which is generally viewed favorably by investors.

Positives

• The vesting of Restricted Stock Units indicates the continued service of a key director, Myrtle S. Potter, aligning her interests with shareholders.
• The acquisition of 10,822 shares of Class A Common Stock increases the director's direct beneficial ownership in the company, demonstrating confidence.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing is a routine insider transaction report (Form 4) detailing a director's compensation-related stock acquisition. It does not provide broader industry context or trends, but reflects standard practices for executive and director equity compensation in publicly traded companies, particularly in the biotechnology or synthetic biology sector where Ginkgo Bioworks operates.

Corporate Governance

Related Party Transactions

• The acquisition of 10,822 shares by Director Myrtle S. Potter through RSU vesting is a transaction between the company and a related party (a director) as part of her compensation under the Non-Employee Director Compensation Program.

Stakeholder Impact

• Shareholders: The transaction increases a director's direct ownership, potentially signaling confidence and aligning the director's financial interests with those of the shareholders.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Keywords

Ginkgo Bioworks Holdings, DNA, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Director Compensation, Stock Acquisition, Myrtle S. Potter